Best CTEM Platforms in 2026: 8 Vendors Compared
Key takeaways
- There is no single best CTEM platform. Scanner-heritage vendors give the widest native coverage, ecosystem vendors win if you already run their stack, and correlation platforms suit teams with tool sprawl.
- Gartner defined CTEM in July 2022 as a five-stage program and predicted organizations running one would be three times less likely to suffer a breach by 2026.
- The first Magic Quadrant for Exposure Assessment Platforms landed 10 November 2025 and assessed 20 vendors. Tenable, Qualys and Rapid7 were named Leaders.
- CTEM is a program, not a product. No tool implements all five stages for you.
- Coverage thins sharply after discovery. Validation is often a paid add-on and mobilization is where most programs stall.
- Gartner projects unified exposure management platforms will grow from under 5% of the market in 2025 to at least half by 2028.
A CTEM platform is a tool that supports Gartner’s five-stage Continuous Threat Exposure Management cycle: scope, discover, prioritize, validate, and mobilize. No single product wins for everyone. Scanner-heritage vendors like Tenable and Qualys give you the widest native coverage, ecosystem vendors like Microsoft and CrowdStrike make sense if you already run their stack, and correlation platforms suit teams drowning in tools they already own.
This compares eight vendors, explains what each stage means in practice, and answers the question most buyer guides avoid: what happens after a platform hands you a prioritized list.
What is a CTEM platform?
A CTEM platform is software that operationalizes continuous threat exposure management, a program Gartner defined in its July 2022 report Implement a Continuous Threat Exposure Management (CTEM) Program. The headline prediction attached to it was that organizations prioritizing security investments through a continuous exposure program would be three times less likely to suffer a breach by 2026.
CTEM is a program, not a product, and that distinction decides how you should read every vendor claim in this category. Vendors sell tools that support parts of the cycle. Since 2022, nearly every vulnerability management vendor has repositioned around the term, which is why Gartner’s own tool category is called exposure assessment platforms rather than CTEM platforms.
In November 2025 Gartner published its first Magic Quadrant for Exposure Assessment Platforms, assessing 20 vendors. It also maintains a separate Market Guide for Adversarial Exposure Validation, which tells you something useful on its own: Gartner treats validation as a distinct market, and so do most vendors’ price lists.
The five stages, and what each one costs you
- Scope. Decide which parts of the business matter. Costs nothing but meeting time, is the easiest to skip, and skipping it is why most programs stall. A scope of “everything” produces a queue nobody can act on.
- Discover. Find assets and exposures across internal, external, cloud, and identity. Every vendor is strong here. Treat broad discovery as table stakes, not a differentiator.
- Prioritize. Rank by real risk rather than CVSS alone. Quality depends on threat intelligence and asset context: whether the platform knows a system is internet-facing, holds regulated data, or has a known-exploited vulnerability.
- Validate. Prove an exposure is reachable and exploitable. Sold under names like attack path analysis, breach and attack simulation, or adversarial exposure validation. Frequently a separate SKU.
- Mobilize. Get the fix done. The stage with the fewest honest answers, because it needs asset ownership data, ticketing integration and workflow, not another dashboard.
Coverage thins as you move down that list. Discovery is a solved problem. Mobilization mostly is not. When you compare vendors, weight the last two stages heavily, because that is where the differences are real.
CTEM platform comparison
| Vendor | Strongest at | Validation | Best fit |
|---|---|---|---|
| Tenable | Discovery, prioritization | Attack path analysis included | Broad native coverage, vulnerability-led programs |
| Qualys | Discovery, risk scoring | Included in TruRisk | Teams standardizing on one scanner |
| Rapid7 | Discovery, external surface | Sold separately | Existing InsightVM estates |
| Microsoft | Identity and endpoint context | Built into Defender | Microsoft-committed stacks |
| CrowdStrike | Endpoint-led exposure | Included | Falcon customers |
| Wiz | Cloud exposure and attack paths | Cloud-focused | Cloud-native environments |
| Brinqa | Correlation across tools | No native scanning | Multi-vendor estates with tool sprawl |
| IONIX | External attack surface | External validation | Internet-facing exposure |
The vendors in detail
Scanner-heritage platforms
Tenable was named a Leader in the 2025 Magic Quadrant and positioned highest for Ability to Execute and furthest right for Completeness of Vision. Its strength is breadth: vulnerability management, external attack surface, cloud, identity and OT under one platform, with attack path analysis included rather than sold separately. The trade-off is that breadth arrives as a large platform with a corresponding implementation effort, and licensing gets complicated across asset types.
Qualys was also named a Leader. Its Enterprise TruRisk Platform folds scanning, risk scoring and remediation into one stack with a single agent, which is attractive for teams that want to standardize rather than integrate. Risk scoring is native rather than bolted on. It suits organizations willing to make Qualys the system of record for exposure.
Rapid7 consolidated its portfolio into the Command Platform, with Exposure Command as the exposure product, built on the InsightVM engine and layering external attack surface visibility and cloud security into tiered packages. It was named a Leader too. Validation is the thing to check in the contract: continuous red teaming is sold as an adjacent product rather than bundled.
Ecosystem platforms
Microsoft is compelling when you already run Defender and Entra, because the identity and endpoint context it brings to prioritization is difficult for an outside tool to reconstruct. Knowing which account is privileged and which device is non-compliant changes what “critical” means. The limit is coverage outside the Microsoft estate.
CrowdStrike approaches exposure from the endpoint outward, which gives strong runtime context: not just that a vulnerability exists, but whether the vulnerable component is actually loaded. For Falcon customers the marginal cost of adding exposure management is low. For everyone else, agent deployment is the entry fee.
Wiz is the strongest option for cloud-native environments. Its attack path graph across cloud misconfigurations, identities and workloads is the reason it wins evaluations where the estate is mostly cloud. It is not the tool for on-premises, OT, or an external brand-facing attack surface.
Correlation platforms
Brinqa performs no scanning of its own. It ingests findings from a large connector library, normalizes them into a risk graph, and drives remediation through policy automation. That makes it the right answer for the specific problem of six tools producing 40,000 findings with no shared identity for an asset, and the wrong answer if your problem is that you cannot see your estate in the first place.
IONIX focuses on the external attack surface, including the dependency chain of third-party assets connected to yours. It fits organizations whose main exposure is internet-facing and whose internal vulnerability management is already handled.
How do you choose a CTEM platform?
Pick based on where your program actually breaks. Three patterns cover most teams.
- You cannot see everything. Discovery is the gap. Scanner-heritage vendors with strong external attack surface coverage fit best.
- You see too much. Six tools, 40,000 findings, no agreement on which asset is which. A correlation layer will do more than a ninth scanner.
- Nothing gets fixed. Findings are accurate and still open after 90 days. Your gap is mobilization, and no assessment tool solves it.
Then make every vendor demonstrate the same thing on your live data, not on a demo tenant: take one exposure from discovery to a closed ticket with a named owner. Most demos stop at a ranked list. That is the moment you learn what you are buying.
Four questions worth asking in any proof of concept:
- Which stages are in this price? Get validation and mobilization named explicitly in the quote. Add-on pricing in year two is the most common budget surprise in this category.
- How do you decide something is critical? Ask them to walk through the scoring on one of your own findings. If the answer is CVSS with a multiplier, the prioritization stage is thinner than the marketing suggests.
- What happens to a finding you cannot fix? Exceptions, compensating controls and risk acceptance are daily work. Tools that only model “open” and “closed” create shadow spreadsheets.
- Where does asset ownership come from? Mobilization fails without it. If the platform cannot answer who owns a server, remediation routing is manual regardless of what the workflow engine promises.
Common mistakes
Buying a platform to fix a process problem. If accurate findings sit open for 90 days, the constraint is ownership and accountability. New tooling adds findings to a queue nobody is working.
Scoping to everything. Gartner puts scoping first for a reason. Programs that begin with the full estate produce a backlog so large that prioritization becomes meaningless.
Treating the Magic Quadrant as a shortlist. Placement measures vendor execution and vision, not fit for your environment. A Leader with no OT coverage is the wrong choice for a manufacturer.
Ignoring validation cost until renewal. Validation is where a program stops drowning in theoretical criticals. If it is a separate SKU, budget it in year one.
Where exposure assessment stops
Exposure assessment platforms find and rank exposures. That is the category Gartner assessed in 2025, and it is a different job from running the whole cycle.
In 2026 Gartner segmented the market further and named unified exposure management platforms (UEMPs) as products that run discovery, aggregation, prioritization, validation and action natively in one system. Gartner projects UEMPs will grow from under 5% of the exposure management market in 2025 to at least half of it by 2028. The direction is toward fewer handoffs, not more tools.
The practical test is simple. If your findings are accurate and your mean time to remediate has not moved in two quarters, adding assessment capacity will not help. Read our guide to unified exposure management platforms for how the categories differ, see how Hunto approaches exposure management end to end, or read how attack surface management feeds the discovery stage.
Frequently asked questions
What is the difference between CTEM and vulnerability management?
Vulnerability management finds and tracks software flaws on known assets. CTEM is broader and continuous. It covers every exposure type including misconfigurations, identity weaknesses and internet-facing assets you did not know you had, and it adds validation and mobilization stages that vulnerability management does not include.
Is CTEM a product or a program?
CTEM is a program. Gartner defined it as a five-stage operational cycle, not a product category. Vendors sell platforms that support the cycle, which is why the tool category Gartner assesses is called exposure assessment platforms rather than CTEM platforms.
Which CTEM vendors were named Leaders by Gartner?
In the first Magic Quadrant for Exposure Assessment Platforms, published 10 November 2025, Tenable, Qualys and Rapid7 were named Leaders among 20 vendors assessed. Tenable was positioned highest for Ability to Execute and furthest right for Completeness of Vision.
How much does a CTEM platform cost?
Pricing is almost always asset-based and quoted per environment, so public list prices are rare. Budget for the validation and mobilization stages separately. Several vendors package attack path analysis or continuous red teaming as an add-on rather than including it, which is the most common source of a surprise in year two.
Do you need a CTEM platform if you already run vulnerability scanning?
Not necessarily. If your scanner covers your estate and findings get remediated on schedule, adding a platform adds cost without closing a gap. The case for one is strongest when exposures span tools that do not talk to each other, or when accurate findings sit open because nobody owns the fix.
What is adversarial exposure validation?
Adversarial exposure validation is the practice of testing whether an exposure is actually reachable and exploitable in your environment, using techniques such as attack path analysis, breach and attack simulation, or continuous automated red teaming. Gartner maintains a separate Market Guide for it, and most vendors price it as a distinct product.
How long does it take to implement a CTEM program?
Expect the first scoped cycle to run in weeks rather than months if you limit the initial scope to one business-critical area. Programs that begin by scoping the entire estate typically stall at the prioritization stage, because the resulting backlog is too large to act on and nobody owns the queue.
